Helpline Tollfree +1.800.650.8239 info@clearsynth.com

OUR QUALITY: ISO 9001:2015 | ISO 14001:2015 | OHSAS 18001:2007 | ISO Guide 34:2009 | ISO/IEC 17025:2005

We speak your language 

2,6-Dichlorobenzamide

Impurities
CAT No.
:
CS-O-11101

CAS No.

:

2008-58-4

Molecular Weight

:

190.02

Molecular Formula

:

C7HCl2NO

Purity

:

>98%

Inventory Status:

:

Available for Immediate Shipment

HS Code:

:

29049090

 

Purchase Online

Price 1 ( USD ) :

100.00 / 25mg

X

Units

Price 2 ( USD ) :

150.00 / 50mg

X

Units




Money
Back Guarantee

48 Hours Delivery
(For In-stock compounds)

Online
Purchase Protection


Useful information

"Vemurafenib (INN, marketed as Zelboraf) is a B-Raf enzyme inhibitor developed by Plexxikon (now part of Daiichi-Sankyo) and Genentech for the treatment of late-stage melanoma. The name \"vemurafenib\" comes from V600E mutated BRAF inhibition.",""



Product Application Notes

Vemurafenib Impurity;Impurity in commercial preparations of Vemurafenib



Synonyms

2,6-Dichlorobenzamide;Vemurafenib Impurity;



References

Halaban, R. et al.: Pigm.cell. Melonoma Res., 23, 190 (2010); Yang, H. et al.:cacer Res., 70, 5518 (2010);comin-Anduix, B. et al.:clin.cacer Res., 16, 6040 (2010);



MSDS



Have any questions ?

We normally respond within 8 hours.

Subject :

  Stock Status

  Bulk Pricing

  Custom QTY Quote

  Request MSDS

  Request COA

  Other






Page info:

This page contains information about 2,6-Dichlorobenzamide Cas # 2008-58-4 and its Impurities.

2,6-Dichlorobenzamide 2,6-Dichlorobenzamide Worldwide Suppliers of 2,6-Dichlorobenzamide Impurities Clearsynth 2008-58-4

Regular price: $100 In stock

Product rating: 9 2,6-Dichlorobenzamide based on 20 ratings

  1. Impurities

  2. 2,6-Dichlorobenzamide



Keywords

Keywords: Impurities 2,6-Dichlorobenzamide;Vemurafenib Impurity; CS-O-11101 2,6-Dichlorobenzamide Vemurafenib 2008-58-4 190.02 C7HCl2NO
Internal standard, Internal standard Vemurafenib, HPLC-MS method validation, HPLC-MS method validation Vemurafenib, LC-MS-MS method validation, LC-MS-MS method validation Vemurafenib, Deuterated internal standard, Deuterated internal standard Vemurafenib, Deuterated Vemurafenib, Deuterium labeled Vemurafenib, Quantitative bioanalytical methods, Quantitative bioanalytical methods Vemurafenib, Blood samples Vemurafenib, Blood concentrations, Heavy drugs, Analysis, Analysis Vemurafenib, Clinical diagnostic, Clinical diagnostic Vemurafenib, Dosing Vemurafenib, Analytical method development, Internal standard method.



Related result for '2,6-Dichlorobenzamide'

- Vemurafenib : API Standards

- Vemurafenib : Impurities

- Vemurafenib : Intermediates



QUICK ENQUIRY

Specific product requirements



Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(






NORTH AMERICAN SALES AND R&D CENTRE

CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060

ASIA R&D CENTRE

CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
Hyderabad- 500076,
Telangana, India.
T : +91-40-27155481

ASIA OFFICE

CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
India
T : +91-22-45045945